Remarkably, BC risk-associated SNPs identified by GWAS were enriched in the binding sites for the transcription factors FOXA1 and estrogen receptor 1 (ESR1) [7], which suggested FOXA1 contributes to BC development by regulatory mechanisms related to estrogen receptor (ER) signaling [8, 9]. Here, FOXA1 is linked to breast cancer.